Fennec Pharmaceuticals (NASDAQ: FENC)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Fennec Pharmaceuticals (NASDAQ: FENC) through any online brokerage.
There are no as such competitors for Fennec Pharmaceuticals.
The latest price target for Fennec Pharmaceuticals (NASDAQ: FENC) was reported by HC Wainwright & Co. on Thursday, June 3, 2021. The analyst firm set a price target for 14.00 expecting FENC to rise to within 12 months (a possible 151.35% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Fennec Pharmaceuticals (NASDAQ: FENC) is $5.57 last updated June 24, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.58 per share of Class A Common Stock. The quarterly cash dividend was payable on April 29, 2016 to stockholders of record on April 22, 2016.
Fennec Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Fennec Pharmaceuticals.
Fennec Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.